CHD vs FDMT · P/E 32, rev $6.11B vs rev $37.0K
Church & Dwight Company Inc (CHD) versus 4D Molecular Therapeutics Inc (FDMT) — a side-by-side from cached financials, not a winner call.
Church & Dwight Company Inc (CHD) is a household & personal products company listed on NYSE.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported CHD revenue for 2024-12-31 was $6.11B. Net income was $585.3M. Revenue was up 4.1% from 2023-12-31 to 2024-12-31. CHD currently screens at market cap $23.08B and trailing P/E 32.0.
Latest reported FDMT revenue for 2024-12-31 was $37.0K. Net income was -$160.9M. Revenue was down 99.8% from 2023-12-31 to 2024-12-31. FDMT currently screens at market cap $518.1M.
CHD currently screens at market cap $23.08B and trailing P/E 32.0. FDMT currently screens at market cap $518.1M.
Not investment advice. Open the CHD and FDMT stock pages for the full models.
Not investment advice.